|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.5 INR | -0.28% |
|
-0.83% | -12.63% |
| 03-30 | Sandu Pharmaceuticals Limited Appoints Shri Vijay Kajrekar as Chief Financial Officer | CI |
| 03-30 | Sandu Pharmaceuticals Limited Announces Executive Changes | CI |
Sandu Pharmaceuticals Limited announced that the Board of Directors at their Meeting held on Feb. 14, 2022 approved incorporation of a wholly owned subsidiary of the Company. The Incorporation of the wholly owned subsidiary will leverage the growth opportunities and will help the Company in becoming more broad based and focused.
Name: Sandu Phytoceuticals Private Limited or any other name as may be approved by Ministry of Corporate Affairs. Proposed authorized capital is INR 100,000.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.63% | 6.89M | |
| +37.29% | 6.02B | |
| -21.28% | 4.19B | |
| +4.52% | 3.25B | |
| -18.16% | 2.87B | |
| -7.70% | 2.37B | |
| +41.50% | 1.89B | |
| -4.05% | 1.58B | |
| -15.56% | 1.54B | |
| -14.62% | 1.5B |
SANDU PHARMACEUTICALS LIMITED 
